Newsroom

AUGUST 16, 2017 Glytec Announces Fourth FDA 510(k) Clearance for Its Market-Leading Diabetes Therapy Management Software The company’s eGlycemic Management System® featuring Glucommander™ has the broadest indications for use of any decision support solution for insulin titration. WALTHAM, MA — The pioneer of diabetes therapy management software, Glytec announces its fourth FDA clearance, adding...

June 20, 2010 Glytec Announces FDA 510(k) Clearance on G+ Enterprise Edition Insulin Dosing Software Glytec announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its G+ System Enterprise Edition, the next generation of the industry standard sophisticated insulin management software system. Glytec, LLC, a wholly-owned subsidiary of GlucoTec, Inc.,...